On Tuesday, direct-to-consumer genetic testing firm 23andMe announced it would be shuttering its much-hyped drug development ...

Home genetics company 23andMe continues to struggle as demand for casual gene tracing declines. On Monday, the company ...

BLOOMBERG NEWS 23andMe is laying off 40 percent of its workforce, or more than 200 employees, and discontinuing its ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Me announced on Monday it would cut 40% of its workforce, representing more than 200 employees, as part of a restructuring at ...

They have also discontinued the therapeutic development programs. CNN confirmed the news of 23andMe’s latest shakeup, as the genetic testing firm has faced multiple internal disputes in the past year.

The restructuring efforts at 23andMe highlight the ongoing challenges faced by companies in the rapidly evolving genetic ...

NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...

More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs ...

In the wake of a big data breach and a sizable new round of layoffs, concerns about the 23andMe's handling of sensitive ...

Sales for the Atlanta-based company improved 6.6 percent to $40.22 billion, topping the $39.31 billion that analysts ...